| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/10/2007 | WO2006083516A3 Modified cyanovirin-n polypeptide |
| 05/10/2007 | WO2003076567A3 Heterologous g-csf fusion proteins |
| 05/10/2007 | WO2002051860A3 Synthetic peptide composition as immunogens for prevention of urinary tract infection |
| 05/10/2007 | US20070107073 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 05/10/2007 | US20070106065 TAT- 001 and methods of assessing and treating cancer |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105799 Codon-optimized polynucleotide-based vaccines against Bacillus anthracis infection |
| 05/10/2007 | US20070105794 Immunotherapy |
| 05/10/2007 | US20070105225 DNA and proteins or peptides specific of bacteria of the Neisseria meningitidis species, methods for obtaining them and biological applications thereof |
| 05/10/2007 | US20070105219 Retrovirus from the HIV group and its use |
| 05/10/2007 | US20070105198 Genetic engineering; libraries; lung cells; hybrids; process control; controlling activation; antiinflammatory agents; autoimmune diseases; infections; bone disorders; anticancer agents; drug screening |
| 05/10/2007 | US20070105193 Severe acute respiratory syndrome DNA vaccine compositions and methods of use |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070104776 Drug having regulatory cell ligand contained in liposome |
| 05/10/2007 | US20070104739 Equine protozoal myeloencephalitis vaccine |
| 05/10/2007 | US20070104738 Extracellular vesicles from non-pathogenic amoebae useful as vehicle for transferring a molecule of interest to an eukaryotic cell |
| 05/10/2007 | US20070104737 Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy |
| 05/10/2007 | US20070104736 Culturing a non-typeable Haemophilus influenzae strain having a mutation in htrB gene, wherein the htrB mutation produces a mutant non-typeable Haemophilus influenzae; purifying the mutant endotoxin |
| 05/10/2007 | US20070104735 Administering a whole cell of a Rhodococcus, Gordona, Nocardia, Dietzia, Tsukamurella or Nocardioides bacterium to treat an autoimmune disease including arteriosclerosis, myointimal hyperplasia, inflammatory and autoimmune thickening of the intima and/or muscular layer of blood vessels and myocarditis |
| 05/10/2007 | US20070104734 Recombinant viruses with heterologous envelope proteins |
| 05/10/2007 | US20070104733 Tissue targeted antigenic activation of the immune response to cancers |
| 05/10/2007 | US20070104732 Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism |
| 05/10/2007 | US20070104731 Helicobacter proteins and vaccines |
| 05/10/2007 | US20070104726 Multimeric complexes of antigens and adjuvants |
| 05/10/2007 | US20070104725 Use of modified extracellular matrix proteins in diagnosis and treatment of atherosclerosis |
| 05/10/2007 | US20070104724 Attaching substances to microorganisms |
| 05/10/2007 | US20070104722 Targeted biocides |
| 05/10/2007 | US20070104721 Antineoplastic combinations with mTOR inhibitor,herceptin, and/or hki-272 |
| 05/10/2007 | US20070104720 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 05/10/2007 | US20070104719 Caspase Activated Prodrugs Therapy |
| 05/10/2007 | US20070104718 Gene BRCC-1 and diagnostic and therapeutic uses thereof |
| 05/10/2007 | US20070104717 Compositions and methods for detecting and treating cancer |
| 05/10/2007 | US20070104716 Methods for controlling pathological angiogenesis by inhibition of a6b4 integrin |
| 05/10/2007 | US20070104715 Alzheimer's disease, systemic amyloidosis and other amyloid disorders; kits |
| 05/10/2007 | US20070104714 Composition and method for the treatment of cancer and other physiologic conditins based on modulation of the ppar-gamma pathway and her-kinase axis |
| 05/10/2007 | US20070104713 Nogo receptor homologs |
| 05/10/2007 | US20070104712 Treatment of Inflammatory Bowel Disease with IFN-Gamma Inhibitors |
| 05/10/2007 | US20070104711 Using tumor necrosis factor inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders |
| 05/10/2007 | US20070104710 Immunoglobulin variable domain; competitive binding; treating allergic hypersensitivity, asthma |
| 05/10/2007 | US20070104709 Non-naturally occurring ligand for umami taste and sweet taste receptor; enhancing response to artificial flavoring |
| 05/10/2007 | US20070104708 Compositions, methods, and kits relating to resistin |
| 05/10/2007 | US20070104707 using compounds that increase endothelial nitric oxide synthase levels to treat pre-eclampsia and eclampsia |
| 05/10/2007 | US20070104689 Compositions and methods for treating tumors presenting survivin antigens |
| 05/10/2007 | US20070104686 Vaccines, immunotherapeutics and methods for using the same |
| 05/10/2007 | US20070104685 Synthetic gene encoding human carcinoembryonic antigen and uses thereof |
| 05/10/2007 | US20070104681 Inhibits Interleukin T Cell Inducible Factors (IL-TIF/IL-22)'s effect on cells |
| 05/10/2007 | US20070104647 Ovr115 antibody compositions and methods of use |
| 05/10/2007 | DE102005053011A1 Use of tetraorganosilicon compound having cell proliferation inhibitory activity, e.g. as an immunstimulator to treat viral-, bacterial- and/or tumor diseases, anemia, arteriosclerosis, arthritis, asthma, autoimmune disease, and cirrhosis |
| 05/10/2007 | CA2638166A1 Cytotoxic antibodies targeting antibodies inhibiting factor viii |
| 05/10/2007 | CA2628477A1 Inhibition of autophagy genes in cancer chemotherapy |
| 05/10/2007 | CA2628462A1 A method for preparing a textile material and a textile material thus prepared and produced |
| 05/10/2007 | CA2628424A1 Adjuvanted influenza vaccines including cytokine-inducing agents |
| 05/10/2007 | CA2628397A1 Changing th1/th2 balance in split influenza vaccines with adjuvants |
| 05/10/2007 | CA2628379A1 Adminstration routes for priming/boosting with influenza vaccines |
| 05/10/2007 | CA2628333A1 Influenza vaccines extemporaneously adsorbed to aluminium adjuvants |
| 05/10/2007 | CA2628328A1 Influenza vaccines including combinations of particulate adjuvants and immunopotentiators |
| 05/10/2007 | CA2628226A1 Use of a liquid allergy vaccine formulation for oromucosal administration |
| 05/10/2007 | CA2628221A1 Compositions and methods for diagnosing and treating cancer |
| 05/10/2007 | CA2628206A1 Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant |
| 05/10/2007 | CA2628158A1 Emulsions with free aqueous-phase surfactant as adjuvants for split influenza vaccines |
| 05/10/2007 | CA2628152A1 Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture |
| 05/10/2007 | CA2628105A1 Uses of anti-cd40 antibodies |
| 05/10/2007 | CA2628084A1 Compositions with antigens adsorbed to calcium phosphate |
| 05/10/2007 | CA2627976A1 Fed batch culture methods for streptococci |
| 05/10/2007 | CA2627971A1 Cell-derived viral vaccines with low levels of residual cell dna by beta-propiolactone treatment |
| 05/10/2007 | CA2627891A1 Uses of anti-cd40 antibodies |
| 05/10/2007 | CA2627890A1 Antibodies and immunotoxins that target human glycoprotein nmb |
| 05/10/2007 | CA2627598A1 Use of combination of anti-angiogenic substance and c-kit kinase inhibitor |
| 05/10/2007 | CA2627427A1 Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions |
| 05/10/2007 | CA2626875A1 Prime boost vaccine for the protection of equines against equine influenza |
| 05/10/2007 | CA2626866A1 Use of vaccines for the treatment/ prevention of the transmission of influenza pathogens between species |
| 05/10/2007 | CA2626079A1 A lentiviral vector-based vaccine |
| 05/10/2007 | CA2609985A1 Modulation of cell barrier dysfunction |
| 05/10/2007 | CA2608515A1 Production of multivalent virus like particles |
| 05/10/2007 | CA2603775A1 Method of protecting against staphylococcal infection |
| 05/09/2007 | EP1783227A1 Humanized anti-CCR2 antibodies and methods of use therefor |
| 05/09/2007 | EP1783226A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783225A1 AAV structural protein, production and use thereof |
| 05/09/2007 | EP1783224A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1783139A2 Human telomerase catalytic subunit |
| 05/09/2007 | EP1782838A1 Inhibition of infiltration, and cell killing agent |
| 05/09/2007 | EP1782837A2 Hapten-carrier conjugates for use in drug-abuse therapy (nicotine) |
| 05/09/2007 | EP1782836A2 Hapten-carrier conjugates for use in drug-abuse therapy (cocaine) |
| 05/09/2007 | EP1782835A2 Hapten-carrier conjugates for use in drug-abuse therapy |
| 05/09/2007 | EP1782833A2 pH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 05/09/2007 | EP1782827A1 Peptide vaccine for cancer therapy |
| 05/09/2007 | EP1782826A1 PQS and c-diGMP and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 05/09/2007 | EP1782070A2 Tumor-associated antigen profiles in cancer diagnostics and immunotherapy |
| 05/09/2007 | EP1781826A2 Compositions and methods for diagnosis and treatment of orthopoxviruses |
| 05/09/2007 | EP1781703A1 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 05/09/2007 | EP1781689A1 Conjugates and therapeutic uses thereof |
| 05/09/2007 | EP1781332A1 Chn-1/chip-antagonists for the treatment of muscular diseases |
| 05/09/2007 | EP1781327A2 Identifying virally infected and vaccinated organisms |
| 05/09/2007 | EP1781326A2 Induction of an immune response against streptococcus pneumoniae polysaccharides |
| 05/09/2007 | EP1781325A2 Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses |
| 05/09/2007 | EP1781321A1 A method of treating cancer comprising a vegf-b antagonist |
| 05/09/2007 | EP1781269A2 IgE-RETARGETING, FUNCTION-ALTERING MOLECULES (ERFAM) FOR TREATMENT OF ALLERGIC DISEASES |
| 05/09/2007 | EP1781267A2 Methods and reagents for the treatment of immunoinflammatory disorders |